ORIC Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: ORIC Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: ORIC Pharmaceuticals Inc
Rating: 1.57016675
Author: Trendlyne DVM scores

about

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision o...

10.85 -0.25 (-2.25%)

26.04% Fall from 52W High

454.6K

XNAS Volume

XNAS 14 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.2 / 100

Technically Neutral

57.6 / 100

No estimates available

ORIC Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ORIC Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision o...

26.04% Fall from 52W High

SWOT Analysis

ORIC Pharmaceuticals Inc Live Price Chart